chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea & vomiting for several days then went away.  Came back about a month later then vomiting for a week. A week later it was back for a week. Gone for two weeks, back for a week.  January 6, 2016, it returned 24/7.  Vomiting 50-60 times/day.  Worst was 90.
Information has been received from a physician concerning a female friend of a patient's mother who was vaccinated with GARDASIL (dose, route, site and Lot # not reported).  Subsequently the patient experienced enlarged liver after vaccination.  Patient outcome was not reported.  The patient sought unspecified medical attention.  Additional information has been requested.
(R) lateral and post thigh, 3 cm firm induration with slight eyrthema. Not tender.
Initial report received from a patient's parent on 03/Feb/2006. An 11 year old male patient with no pre-existing medical history received a right arm injection of Menactra, lot number and route of administration not reported; a right arm injection of Adacel, lot number and route of administration not reported; and a left arm injection of Measles, Mumps and Rubella Vaccine manufacturer not reported, lot number and route of administration not reported, on 20/Jan/2006. On 21/Jan/2006, one day post-vaccination, the patient developed a four to five inch area of swelling at the injection site of the right arm. He also experienced nausea, stomach pain, headache and a slight rash on his shoulders. The nausea resolved after 1.5 days. Two days post-vaccination, he was not able to eat a normal diet and was eating a diet consisting of toast, waffles and crackers. He was examined by his physician on 25/Jan/2006; and, per the parent, the physician thought the events "may by a reaction to the vaccinations." On 28/Jan/2006, the patient was examined in an emergency room where unspecified x-rays and lab tests were completed. All diagnostic tests were negative. He was re-examined by his personal physician on 31/Jan/2006 and had a fever. He was treated with Aciphex, Tums and Tylenol. At the time of this report, the patient continues with the stomach pain and had not recovered.
pt received vaccine on 10/20/21. Pt called pharmacy on 10/31/21 to report that on approximately 10/28/21, pt's arm began to swell. Pt reported that this seemed a little unusual because it started so long after the date of administration. She experienced the redness and soreness for two days after the injection, but it wasn't until a week later that her arm began to swell. Pt stated the swelling has moved beyond the site of the injection a little down her arm.
DIZZINESS, NAUSEA, DIARRHEA, CLAMMY SKIN, SWEATING, MILD CONFUSION, LOW GRADE FEVER THREE HOURS AFTER SHOT. 24 HOURS LATER INJECTION SITE WAS RED AND HOT TO THE TOUCH, BECAME CELLULITIS. 7 DAYS LATER, ON ANTIBIOTICS FOR INFECTIONS, SYMPTOMS CONTINUE.
Second pregnancy, due date of 12/25/2021. Velamentous cord insertion detected on 20-week anatomy scan.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. Since 12-AUG-2016 to 16-AUG-2016, the RECOMBIVAX HB (lot # L027733, expiration date 13-SEP-2017) was stored in 9 Celsius degrees for 5 days. In September 2016, (excursion day unspecified), the RECOMBIVAX HB (lot # L027733, expiration date 13-SEP-2017) was stored in 8.1 Celsius degrees for 45 minutes. Total time out of range was 120 hours, 45 minutes. There were no previous excursions. The excursions were detected by a data logger. On 27-SEP-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (lot # L027733, expiration date 13-SEP-2017) (dose, route of administration were not reported). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
coughs; Can't smell anything; Food tastes very salty; chills/ shivering; throat closed up; Still felt terrible; slept all day; Felt very ill; Could barley breath; felt like got hit by truck / didn't feel well; pain in back; pain in shoulders/ pain in hip; nausea; "huge heat wave"; sweating everywhere; This spontaneous case was reported by a consumer and describes the occurrence of HEAT EXHAUSTION ("huge heat wave"), HYPERHIDROSIS (sweating everywhere), MALAISE (felt like got hit by truck / didn't feel well), BACK PAIN (pain in back) and OROPHARYNGEAL DISCOMFORT (throat closed up) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arthritis, Diabetes, Blood pressure high, High cholesterol and Scoliosis.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced HEAT EXHAUSTION ("huge heat wave") and HYPERHIDROSIS (sweating everywhere). On 24-Mar-2021, the patient experienced NAUSEA (nausea). On 26-Mar-2021, the patient experienced MALAISE (felt like got hit by truck / didn't feel well), BACK PAIN (pain in back) and ARTHRALGIA (pain in shoulders/ pain in hip). On 27-Mar-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (throat closed up), FEELING ABNORMAL (Still felt terrible), SOMNOLENCE (slept all day), ILLNESS (Felt very ill), DYSPNOEA (Could barley breath) and CHILLS (chills/ shivering). On 31-Mar-2021, the patient experienced COUGH (coughs), ANOSMIA (Can't smell anything) and DYSGEUSIA (Food tastes very salty). The patient was treated with IBUPROFEN for Symptomatic treatment, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, HEAT EXHAUSTION ("huge heat wave"), HYPERHIDROSIS (sweating everywhere), MALAISE (felt like got hit by truck / didn't feel well), BACK PAIN (pain in back), OROPHARYNGEAL DISCOMFORT (throat closed up), FEELING ABNORMAL (Still felt terrible), SOMNOLENCE (slept all day), ILLNESS (Felt very ill), DYSPNOEA (Could barley breath), COUGH (coughs), ANOSMIA (Can't smell anything), DYSGEUSIA (Food tastes very salty), ARTHRALGIA (pain in shoulders/ pain in hip), NAUSEA (nausea) and CHILLS (chills/ shivering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment ibuprofen, Zyrtec
Severe muscle pain at injection site at 630pm. By 10pm my body started to ache from neck, shoulders, body down to legs. Severe chills with shivering for almost 2 hours. Low grade fever 99. Could not walk or stand. Took tylenol at 11pm with little effect, then again at 330am due to chills, muscle aches n spasms in legs, slight headache, very tired and miserable feeling. Slept and woke up at 8am sweating under blankets and feeling less sore muscles. Hydrated with water, and by 9am just feeling tired. Soreness of injection site gone as well as body aches. Just fatigue feeling. Will still go to work on 3-26-2021 after thinking there was no way I can move my body. Not feeling 100% at 943am but much better than earlier flu type feeling.
This spontaneous report as received from a health care worker, via a field representative, refers to a patient of unknown age. The health care worker reported that their office administered a dose of ZOSTAVAX that had an undisclosed expiration date. She stated that the box of 10 vials was "mismatched with various expired dates". The expiration dates were not disclosed to the field representative. Field representative was not provided information on when the box of 10 ZOSTAVAX was received, or other lot/expiration information. A few days later another health care worker reported that on 14-MAY-2013 the patient was vaccinated with ZOSTAVAX (dosing information and route were not provided) Lot no. 0218AA, expiry date 16-MAY-2013 (Lot no. 0218AA is an invalid lot number for ZOSTAVAX) for prophylaxis. The patient received an expired dose of ZOSTAVAX. No adverse effect reported. PQC filed. Additional information has been requested.
At 16:10, pt complains of coughing and itching and edema under each eye. Pt received epinefrine. At 16:20, he started having difficulty breathing. EMS notified, was given Benadryl IM and EMS arrived at 16:25 and assisted then took client to ER. On 5/12/99, client was contacted, mom stated pt had returned to school. Pt received cortisone and Benadryl in the ER.
Patient was at the pharmacy to receive her Havrix and Engerix vaccines on Wednesday 9/7/22.  I noticed that the Havrix vaccine started leaking from the needle while the medication was being administered and the patient and I noticed that it started leaking down her arm.  I stopped administering the dose to see what the next step should be.  I contacted the manufacturer and the representative advised that according to guidance that the dose should be repeated since there is uncertainty if the dose would be effective.  I informed the patient of the recommendation and she accepted my apology and the dose was administered.
pt recv vax 4APR96 & return to clinic w/moderate swelling w/redness on rt arm inj site w/fever;t102.3, p117, R20, BP 156/77;rx APAP, Erythromycin;8APR to ER w/swelling of whole rt upper arm;t103;
Information was received 13-OCT-2016 via telephone call from a registered nurse who reported that an improperly stored dose of GARDASIL 9 was administered to a 9 year old patient on 10-OCT-2016. (Lot # L036301, expiration date 20-DEC-2017 and Lot # M018810, expiration date 28-MAY-2018) It was not specified which lot # was administered to this patient. No adverse effects reported. This report was due to data logger. This is one of several reports from the same source. Additional information was requested.
chills; feelings of nauseousness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200519167 (Pfizer).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), for COVID-19 immunization, reaction(s): "No adverse event". The following information was reported: CHILLS (non-serious), outcome "unknown", described as "chills"; NAUSEA (non-serious), outcome "unknown", described as "feelings of nauseousness".  Additional Information: I had my 4th Pfizer shot yesterday. Shot #1 - no reaction. Shots #2 & #3, started 8-hours post-shot and included chills and feelings of nauseousness. Reaction after 4th shot was more severe: severe chills started after 8-hours, nauseousness including vomiting, diarrhea, etc. No fever. This lasted about 6-hours then began to subside. I'm a little pooped today due to lack of rest, but all will be O.K. I'm just trying to figure out what occurred!  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER_INC-202200516760 Same Reporter, Different Vaccine Dose
Severe pain for months; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (Severe pain for months) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Severe pain for months). At the time of the report, PAIN (Severe pain for months) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was on monoclonal antibodies for joint pain. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not applicable     This case was linked to MOD-2021-075055 (Patient Link).
The patient presented to the pharmacy for Yellow Fever vaccine. She is traveling and was deemed a candidate for the vaccine. After receiving the vaccine, the patient stood up to go to the register and began "feeling funny."  The pharmacist had her sit down in the counseling area where she proceeded to faint. The pharmacy called 911 and the pharmacist checked her vitals. EMS arrived 5 minutes after calling and assessed the patient as having an episode of syncope related to getting an immunizations. They offered to take her to the Emergency Room, however recommended that it was not necessary. She agreed and went home to rest.
He had a fever, body pains, mild headache from last night with malaise. He was given T tylenol 650mg as needed for 48 hours.
pt recv vax 30JUL96 1010AM @ 130PM on 30JUL mom called office described rxn as follows: lt thigh down to knee is red & swollen;very irritable: screaming & crying inconsolable;only settles down for 30-60sec @ a time;t99.1 ax;
Right arm became reddened, swollen hard to touch and quite itchy.  This continued  Thursday, Friday, and Saturday,   I also experienced lethargy on Thursday, Friday, and Saturday.  Saturday evening I went to bed early and slept for 10 hours. Sunday I awoke and started feeling much better.
Case number PHEH2013US001121 is an initial spontaneous report received from a consumer on 11 Jan 2013: This report refers to a 46-year-old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with Flu vaccination (manufacture and batch number: unknown) on an unspecified date in 1999. After vaccination on an unspecified date, she experienced vomiting, fever and dehydration. The outcome, seriousness and causality of the events were not reported.
No adverse symptoms, patient tolerated well. Patient noted upon documentation date of 1st dose was 10Sep21. Patient received 2nd dose on 24Sep21, 7 days early.
This spontaneous report was received from a pharmacist and refers to a 46 year old non-pregnant female patient. The patient's concurrent conditions included asthma and chronic lung disease. The patient did not have any drug reactions or allergies and did not take any concomitant medications. On 14-AUG-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 injection intramuscularly in unspecified arm, lot # L019836, expiration date 24-MAR-2017 (dose was not reported). On 14-AUG-2016, with a few seconds after receiving the dose, the patient experienced burning sensation through the middle of the chest and she felt flushed. Then, on the same day, about 3 hours after receiving the dose of PNEUMOVAX 23, the patient's whole arm, which was injected, felt weak and sore. The patient sought medical attention as she called the pharmacist. It was unknown if any lab diagnostic studies were performed. No treatment was given for the events. Product quality complaint was not involved. The patient recovered from burning sensation through the middle of the chest and feeling flushed on 14-AUG-2016, within a few minutes. The outcome of whole injected arm feeling weak and sore was unknown. The relatedness between all the events and vaccination with PNEUMOVAX 23 was not reported. Additional information has been requested.
Patient received a booster dose prior to 6 months of second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received a booster dose prior to 6 months of second dose) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 vaccine (Lot number :EW0217) on 14-Jun-2021 and Pfizer COVID-19 vaccine (Lot number :EW0181) on 07-Jul-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine and Pfizer COVID-19 vaccine.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received a booster dose prior to 6 months of second dose). On 01-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received a booster dose prior to 6 months of second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
ADMINISTRATION OF VACCINE STORED OUTSIDE OF THE RECOMMENDED CONDITIONS; INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 04-DEC-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 04-DEC-2021, the patient experienced administration of vaccine stored outside of the recommended conditions. On 04-DEC-2021, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine stored outside of the recommended conditions and incorrect product storage was not reported. This report was non-serious.
sleepless noc 8MAY in AM was lethargic w/glassy eyes; poor appetite, cried easily; t101.6 ax; taken to ER as advised by nurse; t103 brought down w/APAP;
9/15/21-Patient here for runny nose, cough, chills, and vomiting. Covid exposure 4 days ago. Received covid vaccine in Feb & March of 2021.     Upper respiratory symptoms Runny nose, cough, and chills started 2 days ago.  Yesterday patient began experiencing chest tightness, difficulty breathing on expiration, and low grade fever.  Continuing to take asthma medication: Symbicort, and allergy medications: Zyrtec and Singulair.  Patient denies loss of taste and smell.  Patient is unable to keep food down, but is drinking water.  Right Ear: Tympanic membrane and external ear normal.  Left Ear: Tympanic membrane and external ear normal.  Nose: Rhinorrhea present.  Mouth/Throat: Posterior oropharyngeal erythema present.  Eyes: Pupils are equal, round, and reactive to light. Conjunctivae and lids are normal.  Cardiovascular: Normal rate, regular rhythm and normal heart sounds.  No murmur heard. Pulmonary/Chest: Effort normal. She has decreased breath sounds in the right lower field and the left lower field. She has no wheezes. She has no rales. She exhibits no tenderness.  Lymphadenopathy:       Head (right side): Submandibular adenopathy present. No submental, no tonsillar, no preauricular, no posterior auricular and no occipital adenopathy present.       Head (left side): Submandibular adenopathy present. No submental, no tonsillar, no preauricular, no posterior auricular and no occipital adenopathy present.    She has no cervical adenopathy.       Right cervical: No superficial cervical, no deep cervical and no posterior cervical adenopathy present.      Left cervical: No superficial cervical, no deep cervical and no posterior cervical adenopathy present.       Right: No supraclavicular adenopathy present.       Left: No supraclavicular adenopathy present.  Neurological: She is alert and oriented to person, place, and time.  Skin: Skin is warm. No rash noted.
30 minutes post vaccine.  IM injection in left deltoid.  Left hand fingers tingling. Intermittent tingling in left forearm.
6 hours after administration of vaccine, quick onset of Extreme dizziness and general malaise, lasting approximately 6 hours, small dose VALIUM, and anti-dizziness drug in ER, rested through night and next day ...symptoms much relieved but not completely after 22 hours.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022 at 5:44 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022 at 5:44 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient received vaccine past its 30 day expiry date on 04-Apr-2022 at 17:44:37, booster. Vaccine went into 2 to 8 degree Celsius thaw state on about 24-Dec-2021. The vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. It was unknown if other vaccines were given on the same day or within one month prior to any dose of as Moderna COVID-19 Vaccine to the patient.  No treatment information was provided
Migraine that lasted five days.  Since my second shot on 4/22/21, I have experienced a total of five migraine events.  Prior to receiving the moderna vaccine my migraines were controlled and and I would only experience one every couple of months lasting no more than a day.
Tingling up and down his left arm, a rash occurred around injection site, left shoulder pain, and stiffening of the right knee.
Headache; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the parent.  A 41 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 41 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue". Additional information: This report was related to a study or programme.  Follow-up attempts completed. No further information is expected.